Synergy and antagonism of inflammatory signaling pathways in cardiovascular disease: from molecular crosstalk to stem cell-based and pharmacological therapeutic strategies
Cardiovascular diseases are driven by dysregulated inflammatory signaling networks in which pathways overlap and interact through synergistic, antagonistic, and feedback mechanisms, yet conventional single-pathway-targeted therapies have shown limited efficacy due to compensatory activation and context-dependent signaling plasticity.